24
Participants
Start Date
December 31, 2010
Primary Completion Date
January 31, 2011
pramipexole extended release
0.375mg once per day for 5 days (cross-over), 0.75mg once per day for 5 days (up-titration), 1.5mg once per day for 5 days (cross-over)
pramipexole extended release
0.375mg once per day for 5 days (cross-over), 0.75mg once per day for 5 days (up-titration), 1.5mg once per day for 5 days (cross-over)
pramipexole immediate release
0.125mg three times a day for 5 days (crossover), 0.5mg three times a day for 5 days (cross over)
pramipexole immediate release
0.125mg three times a day for 5 days (crossover), 0.5mg three times a day for 5 days (cross over)
248.665.86002 Boehringer Ingelheim Investigational Site, Beijing
Lead Sponsor
Boehringer Ingelheim
INDUSTRY